Back

Impact of mitral valve regurgitation severity on clinical outcomes in patients with severe aortic stenosis undergoing TAVI

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Valvular heart disease and infective endocarditis e-posters Intervention ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Vicente Jimenez Franco

Hospital Zambrano Hellion TecSalud, San Pedro Garza Garcia (Mexico)

130 More presentations in this session

Presentation thumbnail
Clinical and echocardiographic characteristics associated with the development of infective endocarditis in patients with significant mitral stenosis
Doctor N. Ngiam (Singapore, SG)
Abstract Slides
Presentation thumbnail
Local or general anesthesia for TAVI surgery? An updated systematic review and meta-analysis.
Doctor Z. Cheng (Chengdu, CN)
Abstract Slides
Presentation thumbnail
Use of left ventricular support devices during transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single center experience
Doctor S. Mahmood (Detroit, US)
Abstract Slides
Presentation thumbnail
Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis
Doctor T. Sugimoto (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Mortality and heart failure in patients with severe tricuspid regurgitation. Risk stratification based on TR severity by CMR
Mrs R. Hinojar Baydes (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Valvular heart disease and infective endocarditis e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources